PPT-A Controlled Trial of Erenumab for Episodic Migraine.

AMG334 Aimovig Goadsby PJ Reuter U Hallström Y Broessner G Bonner JH Zhang F Sapra S Picard H Mikol DD Lenz RA N Engl J Med 2017 37721232132 November 30 2017. Know the Difference to Loosen the Vise. Program Goals. What Is a Migraine?. How Does Migraine Affect Quality of Life?. Episodic vs Chronic Migraine. Profiles of Episodic vs Chronic Migraine. Abbreviations. Kevin M Kapadia, MD. Meriter Medical Group Neurology. Madison, WI. Objectives. Headache Disorders comprise a large portion of inpatient and outpatient primary care, pain medicine, and neurologic care, of which migraine headache disorders are one of the most common.. This program will include a discussion of data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Introduction to CGRP as a Treatment Target in Migraine Prevention. This program will include a discussion of data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Introduction to CGRP as a Treatment Target in Migraine Prevention. yo. w migraine . wwo. aura (defined by ICHD3beta) for at least 1yr . ≥4 and <15 migraine days /. mo. during the 3-month period before screening and during a 4-week baseline phase assessed w handheld electronic diary (ERT) completed daily by the patient (≥ 80% adherence to reporting). , Charles A. Popeney , Raed F. Hashem . Neurologic Etiology of Episodic Abdominal Pain: Epilepsy vs. Migraine . IAIM, 2018; 5(10 ): 179 - 183. Page 179 Case Report Neurologic Etiology of Episodic 215 Chapter 16 and ophthalmologists. Frequently, patients are seen rst by their primary care physicians, and are then referred to ophthalmologists for further testing and management, chiey Migraine without aura. ≥5 . attacks. lasting . 4–72 hours . when untreated. ≥. 2 . of the following. : . Unilateral location. Pulsating quality. Moderate-to-severe pain. Aggravation by physical activity. 1. Queiroz LP, Peres MF, Piovesan EJ et al. . A nationwide population-based study of migraine in Brazil. . Cephalalgia. 2009;29(6):642-9.. 2. Queiroz LP, Silva Junior AA. . The prevalence and impact of headache in Brazi. Apply guideline-based diagnostic and evaluation strategies to diagnose and differentiate migraine from . cluster headache. and other primary and secondary headache disorders. . (competence). Evaluate acute and preventive pharmacologic therapies. *p<0.05, **p<0.01, ***p≤0.001; values shown in black are odds ratios comparing chronic migraine and episodic migraine. AMPP=American Migraine Prevalence and Prevention; COPD=chronic obstructive pulmonary disease; PHQ-9=Patient Health Questionnaire – 9 items. Risk of Hypertension in Erenumab-Treated Patients With Migraine in Clinical Trials and in the Postmarketing Setting. Disclosures. 3. Role . Organization. Advisory Board. Speaker. Clinical Care Solutions, CME Outfitters, Curry Rockefeller Group, DeepBench, Global Access Meetings, KLJ Associates, Academy for Continued Healthcare Learning, Majallin LLC, . 1,2. ~3% of people with episodic migraine per year. 3,4. Migraine. Episodic and chronic migraine. PAG=periaqueductal gray; QoL=quality of life. Adapted from: 1. Aurora. Cephalalgia 2009;29(6):597–605; 2. Aurora & Brin. Headache 2017;57(1):109–125;. Peter J. Goadsby. King’s College London, UK. University of California, Los Angeles, USA. Migraine and Trigeminal Autonomic Cephalalgias: Pathophysiology, Diagnosis and Management. XXVI World Congress of Neurology.